rTMS and Olfactory Training for Parkinson's Disease
NCT: NCT07666477 · COMPLETED
Brief Summary
Background: Olfactory and gustatory impairments are common clinical manifestations in patients with neurodegenerative conditions like Parkinson's disease. These chemosensory deficits significantly impact the quality of life, often preceding motor symptoms. Currently, there is a need for effective non-invasive interventions to improve sensory recovery. Objective: The primary objective of this study is to evaluate the therapeutic efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) combined with olfactory training in restoring chemosensory function. We aim to determine whether this combined approach provides superior outcomes compared to individual therapies or standard care. Methods: This clinical trial involves 120 patients diagnosed with Parkinson's disease. Participants will be randomized into four groups to receive either combined rTMS and olfactory training, isolated rTMS, isolated olfactory training, or a control intervention. The recovery of olfactory function will be measured using validated sensory testing tools (such as Sniffin' Sticks) and Electrogustometry (EGM) to assess neural pathway improvement. Conclusion/Significance: This study aims to provide evidence-based insights into non-invasive neurological rehabilitation for chemosensory dysfunction. The findings may help optimize personalized treatment protocols for patients suffering from sensory impairment, potentially enhancing their overall cognitive and sensory quality of life.
Frequently Asked Questions
What is rTMS and Olfactory Training for Parkinson's Disease?
rTMS and Olfactory Training for Parkinson's Disease is a clinical trial registered under NCT07666477. Current status: COMPLETED.
What is the status of NCT07666477?
The current status of NCT07666477 (rTMS and Olfactory Training for Parkinson's Disease) is: COMPLETED.
When did rTMS and Olfactory Training for Parkinson's Disease start?
rTMS and Olfactory Training for Parkinson's Disease started on 2026-01-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.